Article Information
History
- September 28, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 28, 2021 - 08:10).
- Version 2 (January 1, 2022 - 15:30).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marit J. van Gils1,*,
- A. H. Ayesha Lavell2,#,
- Karlijn van der Straten1,3,#,
- Brent Appelman4,#,
- Ilja Bontjer1,
- Meliawati Poniman1,
- Judith A. Burger1,
- Melissa Oomen1,
- Joey H. Bouhuijs1,
- Lonneke A. van Vught3,6,
- Marleen A. Slim3,6,
- Michiel Schinkel4,
- Elke Wynberg1,5,
- Hugo D.G. van Willigen1,
- Marloes Grobben1,
- Khadija Tejjani1,
- Jonne Snitselaar1,
- Tom G. Caniels1,
- Amsterdam UMC COVID-19 S3/HCW study group&,
- Alexander P. J. Vlaar6,
- Maria Prins3,5,
- Menno D. de Jong1,
- Godelieve J. de Bree3,
- Jonne J. Sikkens2,4,*,
- Marije K. Bomers2,* and
- Rogier W. Sanders1,7,*
- 1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
- 2Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
- 3Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
- 4Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
- 5Department of Infectious Diseases, Public Health Service of Amsterdam, GGD, Amsterdam, the Netherlands
- 6Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands
- 7Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA
- ↵*Correspondence to: r.w.sanders{at}amsterdamumc.nl, m.bomers{at}amsterdamumc.nl, j.sikkens{at}amsterdamumc.nl, m.j.vangils{at}amsterdamumc.nl
↵# These authors contributed equally to this work.
Posted September 28, 2021.
Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants
